Cosmos Health Reports $19.4M in Q2 Revenue
COSM sits 57% above its 52-week low of $0.162 on elevated volume (3.1× avg).
Summary
Cosmos Health announced preliminary record second-quarter revenue of $19.4 million, representing an increase of over 30% year-over-year. The company also reported preliminary record H1 2026 revenue and continues its open market share repurchases. This Q2 update follows the company's Q1 2026 report in May, which had highlighted a going concern warning and increased cash burn. For the micro-cap company, which faces significant financial challenges, these actual revenue figures provide an early data point against its ambitious 2026-2029 revenue guidance issued in late May, and are crucial for evaluating its operational performance and ability to meet future targets.
At the time of this announcement, COSM was trading at $0.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.8M. The 52-week trading range was $0.16 to $1.32. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.